Groundbreaking Paper Claims Outdated Laws and Regulations Are Hindering the UK’s CBD and Medicinal Cannabis Industries


<![CDATA[UNITED KINGDOM, April 20, 2021 – PRESS RELEASE – A groundbreaking paper, released April 20, has revealed the outdated laws and regulations currently hindering the U.K.’s cannabidiol (CBD) and medicinal cannabis industries. The paper calls on the government to review its restrictive approach to the U.K. cannabis industry, which could be worth billions of pounds and create tens of thousands of jobs.Not only would the emergence of a domestic cannabis sector help stimulate the U.K. economy post-pandemic, but it would also transform access for the estimated 1.4 million individuals currently sourcing cannabis illegally for medical reasons, who are in desperate need of affordable cannabis medicine.In November 2018, the government announced medical cannabis could be prescribed for patients by specialist doctors, but so far just three National Health Service (NHS) prescriptions and 6,000 private prescriptions have been issued. Despite being one of the largest exporters of medical cannabis in the world, currently, the U.K. imports 100% of its cannabis medicine and the majority of its CBD products, due to the contradictory legislation on medical cannabis, and the convoluted licensing and regulatory processes required for businesses entering the space. Sadly, patients themselves have largely footed the bill for these issues, with the majority of prescriptions paid for privately by patients and their families.Written by Maple Tree Consultants and Mackrell.Solicitors, the discussion paper is supported by 16 industry heavyweights including Prohibition Partners and the Primary Care Cannabis Network. Its findings refer to distinct areas of the cannabis industry, including CBD, hemp and medical cannabis.Recommendations to Government:Reform the high-THC cultivation/controlled drug license system.Allow the cultivation of the hemp flower to extract CBD under an Industrial Hemp license.Increase the THC limit from 0.2% to 1% to align with international competition.Ensure the application of the Novel Foods Regulation to cannabis-related wellbeing supplements does not impinge upon smaller market participants.Encourage wider, appropriate patient…

Excerpt only …
Source : Groundbreaking Paper Claims Outdated Laws and Regulations Are Hindering the UK’s CBD and Medicinal Cannabis Industries

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.